Delivery Order SPE2DE24DA017-SPE2D626F56S9
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $2,887.50 for a nanoneedle scope (125mm) by the Defense Logistics Agency's Medical Supply Chain on December 12, 2025. The contract utilizes fixed-price pricing with economic price adjustment terms and is scheduled for completion by December 29, 2025. This delivery order was issued without set-aside designation, reflecting Arthrex's competitive position as a...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,066.21 for a nanoneedle scope (125mm) by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 18, 2025. This award utilizes no set-aside designation, reflecting Arthrex's established competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on August 19, 2025, for a Nanoneedle Scope measuring 125mm. This fixed-price contract with economic price adjustment carries a ceiling value of $1,732.50 and is scheduled for completion by September 3, 2025. The contract represents a delivery order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $3,465.00 for a Nanoneedle Scope (125mm) on December 16, 2025, with a completion date of December 31, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency supporting orthopedic surgical...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for a Nanoneedle Scope measuring 125mm, with a ceiling value of $2,310.00. The contract, issued on September 12, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 26, 2025. This award was not set aside...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $1,782.00 with a ceiling of $1,782.00 on December 4, 2025. The delivery order, issued under contract type with fixed-price pricing and economic price adjustment provisions, calls for the delivery of a 38-inch forward-working instrument with two triple-pointed needles (4570178681!#2 FW,38" W/2 TPR NDLS). The contract is...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $1,100.88 by the Defense Logistics Agency's Medical Supply Chain for orthopedic surgical products. The award, issued on December 11, 2025, with an ultimate completion date of December 18, 2025, utilizes a fixed-price contract type with economic price adjustment provisions. This delivery order is issued without set-aside...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $37,219.72 on December 16, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by December 19, 2025. This award carries no set-aside designation, reflecting Arthrex's competitive position...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,072.50 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025. The contract, designated as NEEDLE SCORPIO KNEE 1S, utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of September 16, 2025. The award is not set aside for any specific business type, reflecting Arthrex's competitive...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $3,521.10 for a Nanoneedle Scope (125mm) by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 12, 2025, with performance taking place in Naples, Florida. The contract was awarded without a set-aside designation, reflecting...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F56S9Delivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $2,887.50 for a Nanoneedle Scope, 125mm on December 23, 2025. The contract operates under a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of January 8, 2026. This delivery order is issued without set-aside designation, reflecting Arthrex's established competitive position as a primary federal supplier. The order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures orthopedic surgical instruments and implants to support Department of Defense and Department of Veterans Affairs healthcare facilities. This award is issued as a task order under Arthrex's existing master Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive procurement vehicle valued at $471 billion effective from June 2024 through September 2029. This IDC authorizes streamlined access to Arthrex's full portfolio of orthopedic products and surgical technologies without competitive re-evaluation on individual task orders, enabling rapid procurement of advanced surgical solutions across multiple Veterans Integrated Service Networks and military healthcare facilities. Arthrex continues to serve as prime contractor with direct performance, demonstrating sustained capacity to fulfill federal orthopedic healthcare requirements across the comprehensive range of surgical specialties and product categories that support military personnel and veteran patient populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/22/25 |